Coronavirus: India hits 2 million cases, COVID-19 deaths pass 41,000

A health worker in personal protective equipment (PPE) collects a sample using a swab from a girl at a local health centre to conduct tests for the coronavirus disease (COVID-19), amid the spread of the disease, in New Delhi, India July 4, 2020. (Reuters)

India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million cases of infection and more than 41,000 deaths.

India’s health ministry also reported recoveries as a share of total cases are also growing. India has the third-highest caseload in the world after the United States and Brazil. It has the fifth-most deaths and its fatality rate of about 2 percent is far lower than the other hardest-hit countries. The rate in the US is 3.3 percent, and in Brazil, it’s 3.4 percent, Johns Hopkins University figures showed.

For more on coronavirus, visit our dedicated section.

The health ministry said Friday 62,538 cases were reported in the past 24 hours, raising the nation’s total to 2,027,074. Also, 886 people died, for a total of 41,585.

The caseload in the world’s second-most populous country has quickly expanded since the government began lifting a months-long lockdown hoping to jumpstart a moribund economy. The Indian government is projecting negative economic growth in 2020.

As life cautiously returned to the streets of the capital of New Delhi and financial hub Mumbai, which appear to have passed their peaks, state and local governments elsewhere in India were reimposing lockdowns after sharp spikes in growth.

Read more:

Coronavirus: US lifts advice to avoid all international travel due to COVID-19

UAE’s COVID-19 vaccine trials reach milestone of 5,000 vaccinated volunteers

Lebanon records highest single day coronavirus cases tally after Beirut explosion

India had launched two of the world’s dozen and a half prospective vaccines into human trials, with vaccine-maker Zydus Cadila announcing it had completed phase one trials of its DNA-based vaccine on Thursday.

The country will be vital to global vaccination efforts, regardless of whether its own attempts work. The world’s largest vaccine-maker, the Serum Institute in the central city of Pune, has ramped up capacity to manufacture as many as a billion doses of a vaccine in development by AstraZeneca and the University of Oxford, which is in phase two trials in India and England, and phase three trials in Brazil and South Africa.

Researchers are hoping to launch the Oxford vaccine for emergency use by October.

SHOW MORE
Last Update: Friday, 07 August 2020 KSA 07:59 - GMT 04:59
Top